Cargando…
Pneumonia-targeted lopinavir/ritonavir-based treatment for patients with COVID-19: an early-period retrospective single center observational study
BACKGROUND: Robust evidenced treatment strategy for Coronavirus disease 2019 (COVID-19) has not been established yet. Early, targeted, comprehensive management approach can be essential. METHODS: A lopinavir/ritonavir (LPV/r)-based antiviral treatment was administered to the patients with computed t...
Autores principales: | Kim, Jongkyu, Jung, Jiwoong, Kim, Tae Ho, Kang, Naree, Choi, Hanzo, Oh, Dong Hyun, Ahn, Mi Young, Kim, Su hyun, Hahm, Chorom, Lee, Young Kyong, Park, Keunhong, Hong, Kiho, Choi, Jae-phil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439533/ https://www.ncbi.nlm.nih.gov/pubmed/34521365 http://dx.doi.org/10.1186/s12879-021-06588-5 |
Ejemplares similares
-
Factors Associated with Worsening Oxygenation in Patients with Non-severe COVID-19 Pneumonia
por: Hahm, Cho Rom, et al.
Publicado: (2021) -
Clinical Experience with Use of Remdesivir in the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: a Case Series
por: Lee, Choongman, et al.
Publicado: (2020) -
Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010) -
Lopinavir-Ritonavir-Kombination nicht wirksam
por: Diener, Hans-Christoph
Publicado: (2020) -
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023)